Carl L. Alden

2.1k total citations
65 papers, 1.4k citations indexed

About

Carl L. Alden is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Carl L. Alden has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cancer Research, 13 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Carl L. Alden's work include Carcinogens and Genotoxicity Assessment (22 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Toxic Organic Pollutants Impact (5 papers). Carl L. Alden is often cited by papers focused on Carcinogens and Genotoxicity Assessment (22 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Toxic Organic Pollutants Impact (5 papers). Carl L. Alden collaborates with scholars based in United States, India and Japan. Carl L. Alden's co-authors include R.L. Kanerva, Roderick T. Bunch, Timothy J. Maziasz, Kanwar Nasir M. Khan, Dale L. Morris, Toshimi Usui, Daniel Morton, Jacqueline Brassard, Alane Koki and Randy L. Anderson and has published in prestigious journals such as Blood, Pharmaceutical Research and Food and Chemical Toxicology.

In The Last Decade

Carl L. Alden

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl L. Alden United States 22 441 397 276 183 180 65 1.4k
T.C. Orton United Kingdom 16 271 0.6× 633 1.6× 205 0.7× 115 0.6× 292 1.6× 40 1.4k
John G. DeLuca United States 21 574 1.3× 1.0k 2.5× 366 1.3× 56 0.3× 161 0.9× 37 1.8k
Yasushi Kurata Japan 23 388 0.9× 465 1.2× 119 0.4× 81 0.4× 99 0.6× 59 1.2k
R. Bars France 25 249 0.6× 550 1.4× 386 1.4× 57 0.3× 432 2.4× 51 1.7k
Tsuneo Masui Japan 25 630 1.4× 822 2.1× 177 0.6× 50 0.3× 188 1.0× 65 1.7k
Richard E. Kouri United States 24 789 1.8× 765 1.9× 404 1.5× 57 0.3× 379 2.1× 66 1.6k
Matthew S. Bogdanffy United States 26 742 1.7× 492 1.2× 560 2.0× 38 0.2× 124 0.7× 71 1.9k
J.A. Styles United Kingdom 26 1.2k 2.7× 862 2.2× 565 2.0× 76 0.4× 190 1.1× 76 2.4k
Luigi Robbiano Italy 22 598 1.4× 390 1.0× 326 1.2× 42 0.2× 77 0.4× 70 1.3k
Georges de Sousa France 31 287 0.7× 630 1.6× 518 1.9× 77 0.4× 656 3.6× 76 2.4k

Countries citing papers authored by Carl L. Alden

Since Specialization
Citations

This map shows the geographic impact of Carl L. Alden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl L. Alden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl L. Alden more than expected).

Fields of papers citing papers by Carl L. Alden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl L. Alden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl L. Alden. The network helps show where Carl L. Alden may publish in the future.

Co-authorship network of co-authors of Carl L. Alden

This figure shows the co-authorship network connecting the top 25 collaborators of Carl L. Alden. A scholar is included among the top collaborators of Carl L. Alden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl L. Alden. Carl L. Alden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morton, Daniel, Todd Bourcier, & Carl L. Alden. (2012). Improving Carcinogenicity Assessment. Toxicologic Pathology. 41(2). 263–270. 6 indexed citations
2.
Alden, Carl L., Andrew M. Lynn, Daniel Morton, et al.. (2011). A Critical Review of the Effectiveness of Rodent Pharmaceutical Carcinogenesis Testing in Predicting for Human Risk. Veterinary Pathology. 48(3). 772–784. 35 indexed citations
3.
Maziasz, Timothy J., Vivek J. Kadambi, Lee Silverman, Eric R. Fedyk, & Carl L. Alden. (2010). Predictive Toxicology Approaches for Small Molecule Oncology Drugs. Toxicologic Pathology. 38(1). 148–164. 10 indexed citations
4.
Kramer, Jeffrey A., Sandra W. Curtiss, Kyle L. Kolaja, et al.. (2004). Acute Molecular Markers of Rodent Hepatic Carcinogenesis Identified by Transcription Profiling. Chemical Research in Toxicology. 17(4). 463–470. 43 indexed citations
5.
Sasseville, Vito G., Joan H. Lane, Vivek J. Kadambi, et al.. (2004). Testing paradigm for prediction of development-limiting barriers and human drug toxicity. Chemico-Biological Interactions. 150(1). 9–25. 13 indexed citations
6.
Alden, Carl L., et al.. (2002). Application of Genetically Altered Models as Replacement for the Lifetime Mouse Bioassay in Pharmaceutical Development. Toxicologic Pathology. 30(1). 135–138. 15 indexed citations
7.
Oshiro, Y., et al.. (2001). Morphological Transformation of Syrian Hamster Embryo Cells at pH 6.7 by Bemitradine, a Nongenotoxic Carcinogen. PubMed. 14(2). 121–127. 1 indexed citations
8.
Kreijl, Coen F. van, Rudolf B. Beems, Ronny Fransson-Steen, et al.. (2001). Xpa and Xpa/p53+/- knockout mice: overview of available data.. PubMed. 29 Suppl. 117–27. 40 indexed citations
9.
Oshiro, Y., et al.. (1998). Exploration of the Transformation Potential of a Unique Male Rat Protein Alpha2u-Globulin Using Hamster Embryonic Cells. Toxicologic Pathology. 26(3). 381–387. 3 indexed citations
10.
Alden, Carl L., et al.. (1996). A Critical Appraisal of the Value of the Mouse Cancer Bioassay in Safety Assessment. Toxicologic Pathology. 24(6). 722–725. 31 indexed citations
11.
Snook, Sandra S., et al.. (1996). Pathology of Perbutylated-N-Butyl-1-Deoxynojiromycin (An α-Glucosidase-1 Inhibitor) in Sprague-Dawley Rats. Toxicologic Pathology. 24(5). 531–538. 1 indexed citations
12.
Eurell, Thomas E., et al.. (1991). In vitro evaluation of ocular irritants using corneal protein profiles. Toxicology and Applied Pharmacology. 108(2). 374–378. 3 indexed citations
13.
Phillips, John C., et al.. (1990). Survey of the QSAR and in vitro approaches for developing non-animal methods to supersede the in vivo LD50 test. Food and Chemical Toxicology. 28(5). 375–394. 32 indexed citations
14.
Webb, Denise, et al.. (1990). Assessment of the subchronic oral toxicity of d-limonene in dogs. Food and Chemical Toxicology. 28(10). 669–675. 21 indexed citations
15.
Alden, Carl L., et al.. (1990). Characterization of the Early Ultrastructural and Biochemical Events Occurring in Dichloromethane Diphosphonate Nephrotoxicity. Toxicologic Pathology. 18(4). 661–666. 7 indexed citations
16.
Webb, Denise, et al.. (1989). Acute and subchronic nephrotoxicity of d-limonene in fischer 344 rats. Food and Chemical Toxicology. 27(10). 639–649. 36 indexed citations
17.
Alden, Carl L.. (1986). A Review of Unique Male Rat Hydrocarbon Nephropathy. Toxicologic Pathology. 14(1). 109–111. 92 indexed citations
18.
Alden, Carl L., et al.. (1982). Optimization and Standardization of Male Gonad Weight Determinations in Rats. Toxicologic Pathology. 10(1). 33–37. 2 indexed citations
19.
Kanerva, R.L., et al.. (1982). The Effect of Uniform Exsanguination on Absolute and Relative Organ Weights, and Organ Weight Variation. Toxicologic Pathology. 10(1). 43–44. 3 indexed citations
20.
Alden, Carl L., et al.. (1976). Osteochondromatosis of the Cervical Vertebrae in a Dog. Journal of the American Veterinary Medical Association. 168(2). 142–144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T.C. Orton Breakdown of academic impact, for papers by John G. DeLuca Breakdown of academic impact, for papers by Yasushi Kurata Breakdown of academic impact, for papers by R. Bars Breakdown of academic impact, for papers by Tsuneo Masui Breakdown of academic impact, for papers by Richard E. Kouri Breakdown of academic impact, for papers by Matthew S. Bogdanffy Breakdown of academic impact, for papers by J.A. Styles Breakdown of academic impact, for papers by Luigi Robbiano Breakdown of academic impact, for papers by Georges de Sousa
Rankless by CCL
2026